Arcadia Biosciences Ownership | Who Owns Arcadia Biosciences?
Arcadia Biosciences Ownership Summary
Arcadia Biosciences is owned by 394.82% institutional investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.03% of its assets in Arcadia Biosciences shares.
RKDA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Arcadia Biosciences | 394.82% | - | -294.82% |
Sector | Basic Materials Stocks | 53.61% | 10.31% | 36.08% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2022 | 28 | 27.27% | 2,366,535 | -27.91% | 394 | 0.13% | 13 | 8.33% | 10 | 66.67% |
Sep 30, 2022 | 22 | 15.79% | 3,282,701 | 93.73% | 549 | 0.59% | 12 | 50.00% | 6 | -14.29% |
Jun 30, 2022 | 19 | -24.00% | 1,694,503 | -11.72% | 305 | 0.26% | 8 | -33.33% | 7 | 16.67% |
Mar 31, 2022 | 25 | -7.41% | 1,919,375 | -17.97% | 346 | 0.18% | 12 | -7.69% | 6 | - |
Dec 31, 2021 | 27 | 17.39% | 2,339,761 | -26.00% | 439 | 0.13% | 13 | 44.44% | 6 | 20.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Institutional Extnd Mkt Idx Tr | 14.04K | 1.03% | - |
Fidelity Extended Market Index | 7.47K | 0.55% | -60.00 |
Spartan Extended Market Index Pool E | 1.98K | 0.15% | 1.76K |
Fidelity Total Market Index | 1.63K | 0.12% | - |
Fidelity Series Total Market Index | 1.01K | 0.07% | - |
SSgA U.S. Extended Market Index Class I | 908.00 | 0.07% | - |
State St US Extended Mkt Indx NL Cl C | 908.00 | 0.07% | - |
NT Ext Equity Mkt Idx Fd - L | 419.00 | 0.03% | - |
Northern Trust Extended Eq Market Idx | 419.00 | 0.03% | - |
SSgA U.S. Total Market Index Strategy | 372.00 | 0.03% | 111.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 03, 2025 | Kawakami Mark | Chief Financial Officer | Buy | $1.74K |
Feb 03, 2025 | Schaefer Thomas J. | Chief Executive Officer | Buy | $1.74K |
Aug 01, 2024 | Kawakami Mark | Chief Financial Officer | Buy | $1.44K |
Aug 01, 2024 | Schaefer Thomas J. | Chief Executive Officer | Buy | $1.44K |
Feb 01, 2024 | Schaefer Thomas J. | Chief Financial Officer | Buy | $1.44K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | 2 | - |
2024 Q3 | 2 | - |
2024 Q1 | 1 | - |
2023 Q3 | 1 | - |
2023 Q2 | 1 | - |
RKDA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools